| CAS NO: | 1258597-47-5 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 2mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
Apremilast D5 (CC10004 D5; CC-10004 D5) is the penta-deuterated form of Apremilast (Otezla), which is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) and has been approved for treating psoriatic arthritis. It inhibits PDE4 with an IC50 of 74 nM.
纯度：≥98%
CAS：1258597-47-5
m.cnreagent.com